Glenmark Pharmaceuticals said that its subsidiary Glenmark Specialty S.A. has signed an exclusive marketing and distribution agreement with BeiGene, a global oncology company.
Disclaimer : Mymoneytimes implements extreme caution and care in collecting data before publication. Mymoneytimes does not liable for the adequacy, accuracy or completeness of any given information. Hence we are not liable for any kind of direct or indirect loss caused by the use of such information.